# Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020)

> **NCT06596668** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** bomedemstat
- **DRUG:** carbamazepine

## Key facts

- **NCT ID:** NCT06596668
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-02
- **Primary completion:** 2025-02-05
- **Final completion:** 2025-03-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06596668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06596668, "Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06596668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*